We are a mission-driven and multidisciplinary team of physicists, molecular biologists, geneticists, epidemiologists, computer scientists, chemists, clinicians, drug developers, and entrepreneurs focused on the development and application of AI to patient data to radically transform the discovery and development of new drugs, and ultimately change the way we treat and eventually cure diseases.

Zena Sfeir Gehchan

Isabelle Caffry

Senior Director, Strategy & Corporate Development

Bruce Church, PhD

Chief Mathematics Officer and EVP, Research and Early Development 

Joseph F. Donahue

Chief Business Officer 

Jean-Michel Gries,PhD

President and Chief Operating Officer
Colin Hill

Colin Hill

Chief Executive Officer and Co-Founder
Zena Sfeir Gehchan

Galina Kislukhin, PhD

Senior Director, Operations and Precision Medicine 

Jeanne Latourelle, D.Sc.

Senior Vice President, Precision Medicine
Zena Sfeir Gehchan

Kenneth Levine

Vice President, People and Culture
Zena Sfeir Gehchan

Mitchell Rosen, PhD

Director of Software Engineering
Zena Sfeir Gehchan

Zena Sfeir

Vice President, Marketing

So-Youn Shin, PhD

Senior Director, Precision Medicine

Jerome Windsor 

Senior Vice President, Business Development & Strategic Alliances

Board of Directors

John Maraganore, PhD

Chair of Aitia Board of Directors, Venture Partner at ARCH Venture Partners, Venture Advisor at Atlas Ventures, Executive Partner at RTW Investments. Former founding CEO and Director of Alnylam

Jan Berger, MD, MJ

President & Chief Executive Officer, Health Intelligence Partners, Vice Chair of Aitia Board of Directors

Craig Cimini

Vice President of Strategy and Business Development & Cigna Ventures, Cigna

Rob Coppedge

President and Chief Executive Officer, Echo Health Ventures
Colin Hill

Colin Hill

Chief Executive Officer and Co-Founder

Joel Krikston

Managing Director Venture Investments/Head of Strategic Innovation Alliances, Merck Global Health Innovation Fund 


David W. Miller, PhD

Operating Partner, GHO Capital


Samantha Palmer, PhD

Managing Director, Amgen Ventures


Timothy Thompson 

Independent Director & Former Chairman and Chief Executive Officer, Aptus Health

Adrian Weller, PhD

Senior Research Fellow, University of Cambridge Programme Director, Artificial Intelligence, The Alan Turing Institute

Scientific Advisory Board

coming soon

Our Investors